×

Sen. Blumenthal demands Mylan pay Medicaid full $1.27 billion for alleged EpiPen rebate shortfall

3:30 PM ET Thu, 1 June 2017

Mylan for years had classified EpiPen as a generic product, which are assessed lower rebate rates than brand-name drugs.